About Rebrain
Rebrain, also known as RebrAIn, is a healthcare AI company specializing in precision neurosurgery. The company develops advanced targeting technology for Deep Brain Stimulation (DBS) procedures, primarily addressing neurodegenerative conditions such as Parkinson’s disease (PD) and essential tremor (ET). Their core offering, the Optim MRI software, utilizes sophisticated artificial intelligence algorithms combined with a collaborative health data registry to accurately identify optimal brain regions for surgical intervention.
This AI-driven solution aims to significantly enhance the efficiency, safety, and standardization of neurosurgical workflows. By providing precise, millimetric MRI-guided targeting, Rebrain’s technology seeks to simplify complex patient-specific neurosurgery, potentially reducing operative time and improving patient outcomes. The Optim MRI and OptimDBS software have received both CE Mark and FDA 510(k) clearance, underscoring their regulatory compliance and clinical readiness.
For physicians, Rebrain’s technology offers a streamlined approach to neuromodulation planning, potentially expanding access to cutting-edge neurological care for a greater number of patients worldwide. Beyond its current applications in DBS, the company is actively exploring the extension of its AI platform to other minimally invasive neurosurgical techniques, including radiosurgery and focused ultrasound, further demonstrating its commitment to advancing precision medicine in neurology.
Focus Areas
Business Intelligence
| Key Investors | Karista, Nouvelle Aquitaine CO-Investissement (NACo), Aquitaine Science Transfert (AST), Gold Track, Les Startups de la PTIB, M CAPITAL |
| Partnerships | Medical Horizons S.r.l. (Italy), Duke University, University of Virginia (UVA), Pamplona, UCLA |
| Technology | Cloud-based SaaS (Software as a Service) solution (Optim MRI), supervised AI algorithms, health data exchange platform, MRI sequences for targeting, Software as a Medical Device (SaMD) |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, Rebrain's AI-guided targeting offers a significant advancement in neurosurgical planning. It promises enhanced precision and accuracy in identifying optimal targets for DBS and lesioning procedures, which can lead to improved patient outcomes for Parkinson's disease and Essential Tremor. The streamlined and standardized workflow, coupled with the potential to reduce reliance on intraoperative electrophysiology and enable surgery under general anesthesia, can significantly improve efficiency and patient comfort. The FDA and CE clearances provide a strong assurance of the technology's reliability and safety, making it a valuable tool for expanding access to advanced neuromodulation therapies.
Rebrain's service operates as a cloud-based platform. Physicians upload DICOM compatible MR images, which are then processed by Rebrain's AI algorithms. The platform returns marked MRIs with predicted targets to the healthcare centers for surgical planning. This requires a secure health data exchange platform and compatibility with existing medical imaging systems. The data is hosted on HDS (Health Data Hosting) certified servers to ensure compliance with data privacy regulations like GDPR.
What the Web Says
Rebrain (also known as Rebrain.com or Rebrain LLC) appears to be a company with a focus on IT recruitment and potentially educational services, though information is somewhat fragmented across different platforms. Reviews suggest a mixed bag, with some positive experiences regarding career opportunities and skill development, while others point to issues with management, communication, and job security. The company's presence on major review sites like G2, Capterra, and Glassdoor is limited or non-existent for direct reviews of 'Rebrain' as a product or employer, making a comprehensive assessment challenging.
Overall: MixedStrengths
- Opportunities for career growth and skill development (from limited Glassdoor-like comments)
- Exposure to diverse projects and technologies (inferred from IT recruitment context)
- Potential for remote work flexibility (common in IT recruitment)
- Helpful in finding job opportunities for some candidates (from limited Reddit discussions)
Limitations
- Lack of transparency and poor communication from management (from limited Glassdoor-like comments)
- Issues with job security and sudden terminations (from limited Glassdoor-like comments)
- Unclear company structure and roles (inferred from fragmented information)
- Limited direct reviews on major platforms like G2, Capterra, and Glassdoor for 'Rebrain' specifically
- Some users report being spammed by recruiters (from Reddit)
- Difficulty in getting clear information about services or products
Based on reviews from: Glassdoor (limited mentions/reviews for 'Rebrain' or similar entities), Reddit (various threads discussing 'Rebrain' as a recruiter or platform), G2 (no direct product or company reviews found for 'Rebrain'), Capterra (no direct product or company reviews found for 'Rebrain'), Healthcare IT reviewers (no specific reviews found for 'Rebrain' in this context)
Last updated: 2026-07-20
Videos
News, demos, and interviews about Rebrain.
Videos load interactively. If none appear, search YouTube for Rebrain →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]